NOW AVAILABLE – Final Primer Video- Genomics Enabling Personalised Treatment for Cancer Patients

The Genomic Medicine Special Interest Group have produced a 3-part primer videos – ‘Genomics Enabling Personalised Treatment for Cancer Patients.

The videos aim to improve the understanding of some fundamentals of genomic medicines and the NHS Genomic Medicine Service.

The third and final primer video is now available to watch.

Click here to watch the final video (or this link).

 

Want to listen to more about genomic medicine and learn how it impacts cancer patients and their treatment? Revisit the 1st Genomic Wbinar (24th January 2023) by watching the recording here (available free to BOPA members).

The next Genomics Webinar is on 9th February. There is still time to register.

 

The Genomic Medicine Special Interest Group is a BOPA affiliated group aiming to promote excellence in the pharmaceutical care of patients by supporting the membership to systematically embed genomic medicine and pharmacogenomics into routine care. Find out more about the GMSIG here.

Latest News

By Suriya Marshall on 14th March 2026

Parliamentary Intervention Sparks National Campaign to Protect NHS Staff from Hazardous Medicinal Products (HMPs)

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster London, 10 March 2026: Today, the Safer Healthcare and Biosafety Network (SHBN) launches…

Read article
By Suriya Marshall on 14th March 2026

Clinical Pharmacy Congress. 8th-9th May 2026

Dear BOPA member, We are excited to announce that we have partnered with Clinical Pharmacy Congress 2026. Clinical Pharmacy Congress is the UK’s leading event for clinical pharmacy professionals working across…

Read article
By BOPA Executive Committee on 13th March 2026

First UK Campaign to Protect Healthcare Workers from Exposure to Hazardous Medicinal Products (HMPs) launches in Westminster

London, 10 March 2026: The Safer Healthcare and Biosafety Network (SHBN) launches a new campaign titled “Protecting Healthcare Workers: Safer Handling of Hazardous Medicinal Products” to raise awareness of the dangers…

Read article
By BOPA on 13th March 2026

Invitation to Participate: SWEET-PLUS Study

You are invited to take part in a research study called SWEET-PLUS (NIHR Research for Patient Benefit: 207952), run by Newcastle and Oxford Brookes Universities. SWEET-PLUS aims to understand experiences…

Read article